Accessibility statement

The Cardiac Rehabilitation Outcome Study (CROS)

The prognostic effect of cardiac rehabilitation in the era of acute revascularization and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies. The Cardiac Rehabilitation Outcome Study (CROS). 

The research project aims to:

  • investigate the effectiveness of cardiovascular rehabilitation (CR) in reducing total mortality and other clinical events during follow-up after an acute coronary syndrome (ACS) in the era of acute revascularization and intense medical therapy including statins
  • investigate the effectiveness of CR in reducing total mortality and other clinical events during follow-up after coronary bypass grafting (CABG) in the era of intense medical therapy including statins
  • evaluate essential cardiac rehabilitation conditions and characteristics with respect to their influence on clinical outcome. These include: timing of the start of CR after the index event (ACS or CABG), CR-duration, CR intensity.

PROSPERO 2014:CRD42014007084 

Funder: Pfizer
Start date: November 2013
End date: May 2015
Amount: £15,000

Contact details

Jessica Hemingway
PA to Professor Patrick Doherty & Research Administrator

Tel: 01904 32(1741)